Literature DB >> 20003037

In the vanguard of biomedicine? The curious and contradictory case of anti-ageing medicine.

Jennifer R Fishman1, Richard A Settersten, Michael A Flatt.   

Abstract

The rise of anti-ageing medicine is emblematic of the current conditions of American biomedicine. Through in-depth interviews with 31 anti-ageing practitioners, we examine how practitioners strive for-and justify-a model of care that runs counter to what they see as the 'assembly line' insurance-managed industry of healthcare. Their motivation, however, is not merely a reaction to conventional medicine. It is derived from what they see as a set of core beliefs about the role of the physician, the nature of the physician-patient relationship, and the function of biomedicine. We analyse this ideology to underscore how anti-ageing medicine is built on a 'technology of the self', a self in need of constant surveillance, intervention, and maintenance. The ultimate goal is to create an optimal self, not just a self free of illness. A fundamental irony is that, despite their self-presentation and the perception of the public, anti-ageing providers do not use practices that are especially 'high-tech' or unconventional. Instead, the management of ageing bodies rests on providers' perceived knowledge of their patients, tailored treatments, and a collaborative pact between the provider and patient.

Entities:  

Mesh:

Year:  2009        PMID: 20003037      PMCID: PMC3414193          DOI: 10.1111/j.1467-9566.2009.01212.x

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  5 in total

1.  The war on "anti-aging medicine".

Authors:  Robert H Binstock
Journal:  Gerontologist       Date:  2003-02

Review 2.  The biomedicalization of aging: dangers and dilemmas.

Authors:  C L Estes; E A Binney
Journal:  Gerontologist       Date:  1989-10

3.  Anti-aging medicine: a patient/practitioner movement to redefine aging.

Authors:  Courtney Everts Mykytyn
Journal:  Soc Sci Med       Date:  2005-07-22       Impact factor: 4.634

4.  From the Lab to the Front Line: How Individual Biogerontologists Navigate their Contested Field.

Authors:  Richard A Settersten; Michael A Flatt; Roselle S Ponsaran
Journal:  J Aging Stud       Date:  2008-12-01

5.  Anti-aging science: The emergence, maintenance, and enhancement of a discipline.

Authors:  Jennifer R Fishman; Robert H Binstock; Marcie A Lambrix
Journal:  J Aging Stud       Date:  2008-12-01
  5 in total
  4 in total

1.  Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.

Authors:  Jill A Fisher; Marci D Cottingham; Corey A Kalbaugh
Journal:  Soc Sci Med       Date:  2014-08-19       Impact factor: 4.634

2.  Bioidentical hormones, menopausal women, and the lure of the "natural" in U.S. anti-aging medicine.

Authors:  Jennifer R Fishman; Michael A Flatt; Richard A Settersten
Journal:  Soc Sci Med       Date:  2015-02-19       Impact factor: 4.634

3.  The salience of language in probing public attitudes about life extension.

Authors:  Richard A Settersten; Jennifer R Fishman; Marcie A Lambrix; Michael A Flatt; Robert H Binstock
Journal:  Am J Bioeth       Date:  2009-12       Impact factor: 11.229

4.  Anti-aging technoscience & the biologization of cumulative inequality: Affinities in the biopolitics of successful aging.

Authors:  James Rupert Fletcher
Journal:  J Aging Stud       Date:  2020-10-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.